Immune System Development in Infants Born to Mothers with Autoimmune Disease, Exposed In Utero to Immunosuppressive Agents

ABSTRACT

Exposure to immunosuppressant agents during gestation can affect the fetal immune system. The aim of this study was to evaluate the immune function of infants whose mothers were administered immunosuppressants during pregnancy for the treatment of autoimmune disorders. Circulating lymphocyte subsets and in vitro immunoglobulin production were assessed at birth, and months 1, 6, and 12 of life in 19 infants exposed in utero to glucocorticoid alone or in combination with azathioprine, cyclosporine A, or hydroxychloroquine. The results were compared with those obtained in 15 age-matched infants from mothers with autoimmune diseases not exposed to immunosuppressants. No differences in terms of absolute lymphocyte count, percentage of B and T lymphocytes, and immunoglobulin production were observed. No immune system dysfunction was found in the two studied groups, suggesting a lack of interference between the immunosuppressive treatment and the immune systems of the offspring.

Autoimmune disease - immune system - immunosuppressive agents - infant

REFERENCES

• 1 Motta M, Tincani A, Lojacono A et al.. Neonatal outcome in patients with rheumatic disease.  Lupus. 2004;  13 718-723
• 2 Prevot A, Martini S, Guignard J P. In utero exposure to immunosuppressive drugs.  Biol Neonate. 2002;  81 73-81
• 3 Scott J R. Risks to the children born to mothers with autoimmune diseases.  Lupus. 2002;  11 655-660
• 4 Rose M L, Dominguez M, Levare N. Analysis of T cell subpopulations and cyclosporine levels in the blood of two neonates born to immunosuppressed heart-lung transplant recipients.  Transplantation. 1989;  48 223-226
• 5 Ersay A, Oygür N, Cpskun M, Süleymanlar G, Track B, Yegin O. Immunologic evaluation of a neonate born to an immunosuppressed kidney transplant recipient.  Am J Perinatol. 1995;  12 413-415
• 6 Takahashi N, Nishida H, Hoshi J. Severe B cell depletion in newborns from renal transplant mothers taking immunosuppressive agents.  Transplantation. 1994;  57 1617-1621
• 7 Baarsma R, Kamps W A. Immunological responses in an infant after cyclosporine A exposure during pregnancy.  Eur J Pediatr. 1993;  152 476-477
• 8 Kozlowska-Boszko B, Korczak G, Wierzbicki P et al.. Pregnancy following kidney transplantation: risk for offsprings.  Transplant Proc. 1997;  29 262-265
• 9 Di Paolo S, Schena A, Morrone L F et al.. Immunologic evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipients: analysis of lymphocyte subpopulations and immunoglobulin serum levels.  Transplantation. 2000;  69 2049-2054
• 10 Pilarski L M, Yacyshyn B R, Lazarovits A I. Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero.  Transplantation. 1994;  57 133-144
• 11 Airo P, Antonioli C M, Motta M et al.. The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis.  Lupus. 2002;  11 454-457
• 12 Cimaz R, Meregalli E, Biggioggero M et al.. Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy.  Toxicol Lett. 2004;  149 155-162
• 13 Meregalli E, Biggioggero M, Borghi O, Meroni P, Cimaz R. In vivo effects of maternal immunosuppression during pregnancy on the immune function of newborn infants.  Arh Hig Rada Toksikol. 2005;  56 151-156
• 14 Airò P, Scarsi M, Brucato A et al.. Characterization of T-cell population in children with prolonged fetal exposure to dexamethasone for anti-Ro/SS-A antibodies associated congenital heart block.  Lupus. 2006;  15 553-561
• 15 Cimaz R, Meregalli E, Biggioggero M et al.. Response to tetanus vaccination in infants exposed in utero to immunosuppressants for maternal autoimmune disorders.  Lupus. 2007;  16 129-132
• 16 Marconi M, Plebani A, Avanzini M A et al.. IL10 and IL4 co-operate to normalize in vitro IgA production in IgA-deficient (IgAD) patients.  Clin Exp Immunol. 1998;  112 528-532
• 17 Flechner S M, Katz A R, Rogers A J, Van Buren C, Kahan B D. The presence of cyclosporine in body tissues and fluids during pregnancy.  Am J Kidney Dis. 1985;  5 60-63
• 18 Venkataramanan R, Koneru B, Wang C C, Burckart G J, Caritis S N, Starzl T E. Cyclosporine and its metabolites in mother and baby.  Transplantation. 1988;  46 468-469
• 19 Coté C J, Meuwissen H G, Pickering R J. Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy.  J Pediatr. 1974;  85 324-328
• 20 DeWitte D B, Buick M K, Cyran S E. Neonatal pancytopenia and severe combined immunodeficiency associated with antenatal administration of azathioprine and prednisone.  J Pediatr. 1984;  105 625-628
• 21 Davison J M, Dellagrammatikas H, Parkin J M. Maternal azathioprine therapy and depressed hemopoiesis in the babies of renal allograft patients.  Br J Obstet Gynaecol. 1985;  92 233-239
• 22 Jenkins M K, Schwartz H, Pardoll D M. Effect of ciclosporin A on T cell development and clonal delection.  Science. 1988;  241 1655-1658
• 23 Fukuzawa M, Sharrow S O, Shearer G M. Effect of ciclosporin A on T cell immunity. Defective thymic education of CD4 T helper cell function in ciclosporin A-treated mice.  Eur J Immunol. 1989;  19 1147-1152
• 24 Halloran P F, Madrenas J. The mechanism of action of cyclosporine: a perspective for the 90's.  Clin Biochem. 1991;  24 3-7
• 25 Ramsey-Goldman R, Schilling E. Immunosuppressive drug use during pregnancy.  Rheum Dis Clin North Am. 1997;  23 149-167
• 26 Little B B. Immunosuppressant therapy during gestation.  Semin Perinatol. 1997;  21 143-148
• 27 Bermas B L, Hill J A. Effects of immunosuppressive drugs during pregnancy.  Arthritis Rheum. 1995;  38 1722-1732
• 28 Fox R. Antimalarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development.  Lupus. 1996;  5 S4-S10
• 29 Baxter J D, Forsham P H. Tissue effects of glucocorticoids.  Am J Med. 1972;  53 573-589
• 30 Rhen T, Cidlowski J A. Antiinflammatory action of glucocorticoids. New Mechanisms for old drugs.  N Engl J Med. 2005;  353 1711-1723